Safety of Batracylin in Patients With Solid Tumors and Lymphomas

NCT00450502 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

NIH

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Batracylin

Sponsor

National Cancer Institute (NCI)